Based on their balance sheet (FCF) their NAV is around 54p. They have a diversified investment portfolio and a strong management team. I bid for monies from them once with a spin -out company in the medical technology space, they are savvy investors in my opinion and invest where there is tangible evidence of a forward order book and sales growth, not cash burn....
